Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel vaccine approach stimulates protective immunity against listeria

21.03.2006


Could also protect against other intracellular bacterial pathogens



When bacterial pathogens attack the surface of a cell, vaccine-induced antibodies can mount a formidable defense and fend off the bad bugs. The trouble comes when antibodies cannot recognize the pathogen because the bacteria have infected the cell and are hidden, growing inside the cell’s wall.

To mount a defense against these cloaked attackers, Darren Higgins, Associate Professor of Microbiology at Harvard Medical School, and H.G. Archie Bouwer, Immunology Research Scientist at the Earle A. Chiles Research Institute and Portland VA Medical Center, have developed a vaccine strategy for generating an attenuated strain of an intracellular bacterial pathogen. The study appears in the PNAS online early edition the week of March 20, 2006. The vaccine approach could also protect against other intracellular bacterial pathogens, such as tularemia.


The team has initially applied their strategy to Listeria monocytogenes, which affects the most vulnerable humans – the chronically ill, the elderly, pregnant women, and young children, who are susceptible to a serious infection caused by eating food contaminated with the bacteria. In the United States, an estimated 2,500 persons become seriously ill with the infection each year. Of these, 500 die.

After absorption by antigen presenting cells, the attenuated Listeria strain does not replicate, and is readily killed. Unlike other attenuated Listeria strains that do not replicate in host cells, vaccine studies in animals showed that the new strain provided protection from challenge with a virulent, disease-causing, Listeria strain.

"For the first time, an attenuated strain of Listeria that does not replicate in an animal and does not require any manipulation of the bacterium or host prior to immunization still provides protective immunity," Higgins said.

The team found the replication-deficient vaccine strain of Listeria was cleared rapidly in both normal and immunocompromised mice. At the same time, a required class of T-cells – coordinators of the immune system – was stimulated following immunization. As a result, animals immunized with the vaccine strain were resistant to 40 times the lethal dose of virulent Listeria.

"In theory, we could apply this vaccine strategy to other bacterial pathogens like Salmonella," said Higgins. "All we need is to use existing strains that do not replicate inside host cells."

The new Listeria vaccine was based on a 2002 study performed by the Higgins group in which they developed killed E. coli strains as vehicles for delivering antigens to professional antigen presenting cells in the body. In the prior study, Higgins showed that the E. coli-based vaccines protected mice from developing tumors when challenged with melanoma producing cells.

"We have now taken our E. coli-based cancer vaccine work and expanded it into infectious disease areas," Higgins said. "Our Listeria studies demonstrate the potential to generate vaccine strains of bacteria that are effective, yet safe for both healthy and immunocompromised individuals."

The Higgins and Bouwer team is continuing to improve and expand their approach to other intracellular bacteria.

Judith Montminy | EurekAlert!
Further information:
http://www.hms.harvard.edu

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>